Correlation Between Canntab Therapeutics and Avicanna
Can any of the company-specific risk be diversified away by investing in both Canntab Therapeutics and Avicanna at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Canntab Therapeutics and Avicanna into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Canntab Therapeutics Limited and Avicanna, you can compare the effects of market volatilities on Canntab Therapeutics and Avicanna and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Canntab Therapeutics with a short position of Avicanna. Check out your portfolio center. Please also check ongoing floating volatility patterns of Canntab Therapeutics and Avicanna.
Diversification Opportunities for Canntab Therapeutics and Avicanna
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Canntab and Avicanna is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Canntab Therapeutics Limited and Avicanna in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avicanna and Canntab Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Canntab Therapeutics Limited are associated (or correlated) with Avicanna. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avicanna has no effect on the direction of Canntab Therapeutics i.e., Canntab Therapeutics and Avicanna go up and down completely randomly.
Pair Corralation between Canntab Therapeutics and Avicanna
If you would invest 20.00 in Avicanna on December 29, 2024 and sell it today you would earn a total of 1.00 from holding Avicanna or generate 5.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Canntab Therapeutics Limited vs. Avicanna
Performance |
Timeline |
Canntab Therapeutics |
Avicanna |
Canntab Therapeutics and Avicanna Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Canntab Therapeutics and Avicanna
The main advantage of trading using opposite Canntab Therapeutics and Avicanna positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Canntab Therapeutics position performs unexpectedly, Avicanna can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avicanna will offset losses from the drop in Avicanna's long position.Canntab Therapeutics vs. Bionoid Pharma | Canntab Therapeutics vs. CTT Pharmaceutical Holdings | Canntab Therapeutics vs. Alterola Biotech | Canntab Therapeutics vs. HLS Therapeutics |
Avicanna vs. Pharmacielo | Avicanna vs. Khiron Life Sciences | Avicanna vs. Flower One Holdings | Avicanna vs. Cansortium |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |